14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.71 $3.40 Wednesday, 24th Apr 2024 ESPR stock ended at $2.13. This is 1.91% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.85% from a day low at $2.06 to a day high of $2.16.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Apr 30, 2021 $27.23 $28.03 $26.80 $26.95 238 326
Apr 29, 2021 $27.79 $28.04 $27.16 $27.31 348 712
Apr 28, 2021 $27.23 $27.79 $26.64 $27.46 442 306
Apr 27, 2021 $28.39 $28.62 $26.67 $27.45 1 089 651
Apr 26, 2021 $27.59 $28.75 $27.32 $28.69 361 078
Apr 23, 2021 $28.63 $28.78 $27.49 $27.51 287 972
Apr 22, 2021 $27.50 $28.63 $27.08 $28.22 338 296
Apr 21, 2021 $27.46 $27.85 $26.95 $27.84 268 209
Apr 20, 2021 $26.96 $27.66 $26.63 $27.54 302 766
Apr 19, 2021 $27.00 $27.02 $26.46 $26.89 234 108
Apr 16, 2021 $27.01 $27.29 $25.94 $27.02 315 911
Apr 15, 2021 $27.21 $27.76 $26.90 $27.04 760 542
Apr 14, 2021 $26.26 $27.60 $26.03 $27.15 550 771
Apr 13, 2021 $26.05 $26.45 $25.20 $26.21 469 099
Apr 12, 2021 $26.39 $26.75 $25.65 $26.02 637 522
Apr 09, 2021 $28.02 $28.11 $26.83 $26.95 356 238
Apr 08, 2021 $27.53 $28.55 $27.33 $28.22 488 682
Apr 07, 2021 $27.80 $28.35 $27.37 $27.56 421 838
Apr 06, 2021 $28.71 $29.29 $27.69 $27.75 388 517
Apr 05, 2021 $28.96 $29.08 $27.65 $28.69 476 104
Apr 01, 2021 $28.22 $29.07 $27.81 $28.71 261 666
Mar 31, 2021 $27.48 $28.44 $27.37 $28.05 343 927
Mar 30, 2021 $27.50 $28.39 $26.84 $27.44 362 473
Mar 29, 2021 $27.38 $28.50 $26.52 $27.72 531 366
Mar 26, 2021 $28.03 $28.03 $26.57 $27.39 461 359
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT